RAS Inhibitor Therapy of Cancer

10k
Total downloads
42k
Total views and downloads

Articles

EDITORIAL

Published on 09 Sep 2025

Editorial: RAS inhibitor therapy of cancer

Donald J. Buchsbaum
Nicolas N. Nassar
Gary A. Piazza

doi 10.3389/fonc.2025.1685295

1,061 views

REVIEW

Published on 20 Aug 2025

MAPK-targeted therapies in non-gastrointestinal stromal tumor soft tissue sarcomas: current landscape and future directions

Ouissam Al Jarroudi
Khalid El Bairi
Sami Aziz Brahmi
Said Afqir

doi 10.3389/fonc.2025.1418537

750 views

REVIEW

Published on 24 Jun 2024

Assessment of KRASG12C inhibitors for colorectal cancer

Gary A. Piazza
Preethi Chandrasekaran
Yulia Y. Maxuitenko
Karim I. Budhwani

doi 10.3389/fonc.2024.1412435

4,184 views
5 citations

MINI REVIEW

Published on 22 May 2024

Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance

Jameela Lokhandwala
Tracess B. Smalley
Timothy H. Tran

doi 10.3389/fonc.2024.1394702

5,437 views
12 citations

REVIEW

Published on 10 May 2024

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment

Szu-Aun Long
Amber M. Amparo
Grace Goodhart
Syed A. Ahmad
Andrew M. Waters

doi 10.3389/fonc.2024.1402128

9,099 views
11 citations

REVIEW

Published on 02 May 2024

KRAS G12C inhibitor combination therapies: current evidence and challenge

Hirotaka Miyashita
Shumei Kato
David S. Hong

doi 10.3389/fonc.2024.1380584

19,699 views
33 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Cancer Molecular Targets and Therapeutics

Impact

42kTopic views
30kArticle views
10kArticle downloads